On the other side, IL-23 was found overexpressed in numerous cancers, such as non-small-cell lung carcinoma, colorectal carcinoma, hepatocellular carcinoma, ovarian, breast, pancreatic cancer, malignant melanoma, bladder cancer, and multiple myelomas, and gastric cancer [34]. This evidence concerns the gene IL37 and colorectal carcinoma.